2 years ago
WVE
AnalystsSalim SyedSalim Syed's Stock Forecasts
AnalystsSalim Syed
Sectors:
Industries:
Analyst Ranking
Bottom 7%
#4927 out of 5266 analysts
Average Return
-3.78%
Win Rate
40%29 out of 72
Risk vs Reward
Poor
Good
Salim Syed's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Nkarta IncNKTX | +149.75% | $1.99 | $4.97 | 2023-08-13 - 2024-08-13 | Strong Buy |
Bridgebio Pharma IncBBIO | +149.26% | $11.47 | $28.59 | 2022-08-23 - 2023-08-23 | Strong Buy |
Bridgebio Pharma IncBBIO | +105.55% | $13.52 | $27.79 | 2023-05-07 - 2024-05-07 | Strong Buy |
Cytokinetics IncCYTK | +102.27% | $31.32 | $63.35 | 2025-05-28 - 2026-05-01 | Buy |
Bridgebio Pharma IncBBIO | +89.59% | $35.17 | $66.68 | 2020-02-18 - 2021-02-19 | Strong Buy |
Salim Syed Analyst Color
Get additional color on Salim Syed's coverage of popular stocks
2 years ago
PCVX
2 years ago
NKTX
Salim Syed's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Sutro Biopharma IncSTRO | 1 | Buy | $50.00 | +40.49% | Initiates Coverage On | 4 days ago |
Bridgebio Pharma IncBBIO | 9 | Buy | $106.00 | +54.61% | Reiterates | 6 days ago |
Autolus Therapeutics PLCAUTL | 1 | Buy | $10.00 | +580.27% | Maintains | a month ago |
Syndax Pharmaceuticals IncSNDX | 1 | Buy | $43.00 | +125.01% | Maintains | a month ago |
Nkarta IncNKTX | 9 | Buy | $12.00 | +309.56% | Maintains | a month ago |
Enliven Therapeutics IncELVN | 2 | Buy | $45.00 | +7.91% | Maintains | a month ago |
Wave Life Sciences LtdWVE | 6 | Buy | $27.00 | +268.85% | Maintains | a month ago |
Cytokinetics IncCYTK | 7 | Buy | $100.00 | +57.85% | Maintains | 2 months ago |
Maze Therapeutics IncMAZE | 1 | Buy | $97.00 | +257.01% | Initiates Coverage On | 2 months ago |
Incyte CorpINCY | 1 | Buy | $121.00 | +24.86% | Upgrades | 5 months ago |
Assembly Biosciences IncASMB | 2 | Buy | $40.00 | +46.15% | Maintains | 5 months ago |
Biogen IncBIIB | 14 | Buy | $169.00 | -9.65% | Maintains | a year ago |
Amgen IncAMGN | 6 | Hold | $280.00 | -15.11% | Maintains | a year ago |
Gilead Sciences IncGILD | 6 | Buy | $117.00 | -11.13% | Maintains | a year ago |
Vaxcyte IncPCVX | 3 | Buy | $163.00 | N/A | Maintains | 2 years ago |
Atara Biotherapeutics IncATRA | 4 | Buy | $18.00 | N/A | Upgrades | 2 years ago |
Crispr Therapeutics AgCRSP | 3 | Strong Buy | $99.00 | N/A | Maintains | 2 years ago |
Unity Biotechnology IncUNBX | 5 | Strong Buy | $6.00 | N/A | Maintains | 3 years ago |
Coherus Oncology IncCHRS | 3 | Strong Buy | $21.00 | N/A | Maintains | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.